Syros Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Syros Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 39.3M shares, a 40.7% increase year-over-year.
  • Syros Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 28.3M shares, a 124% increase from 2022.
  • Syros Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 12.6M shares, a 102% increase from 2021.
  • Syros Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 6.25M shares, a 35.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 39.3M +11.4M +40.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 39M +11.1M +40% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 28.3M +15.7M +124% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 28M +18.6M +197% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 27.9M +21.5M +337% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 27.8M +21.5M +342% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 12.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 9.42M +3.12M +49.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 6.38M -56.5M -89.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 6.31M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q3 2021 6.29M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 62.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.